Evidence map›Paper›PMID 37257453›Full record

ArticleCell chemical biology2023

Investigating the NRAS 5' UTR as a target for small molecules.

Sumirtha Balaratnam, Zachary R Torrey, David R Calabrese, Michael T Banco, Kamyar Yazdani, Xiao Liang, Christopher R Fullenkamp, Srinath Seshadri, Ronald J Holewinski, Thorkell Andresson and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell chemical biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. JACS Au · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Investigating Potential 5' UTR G-Quadruplexes Within NRF2 mRNA.Current issues in molecular biology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Identification of RNA structures and their roles in RNA functions.Nature reviews. Molecular cell biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Sumirtha BalaratnamChemical Biology Laboratory, National Cancer Institute, Frederick, MD 21702, USA.
Zachary R TorreyChemical Biology Laboratory, National Cancer Institute, Frederick, MD 21702, USA.
David R CalabreseChemical Biology Laboratory, National Cancer Institute, Frederick, MD 21702, USA.
Michael T BancoBiochemistry and Biophysics Center, National Heart, Lung and Blood Institute, Bethesda, MD 20892, USA.
Kamyar YazdaniChemical Biology Laboratory, National Cancer Institute, Frederick, MD 21702, USA.
Xiao LiangChemical Biology Laboratory, National Cancer Institute, Frederick, MD 21702, USA.
Christopher R FullenkampChemical Biology Laboratory, National Cancer Institute, Frederick, MD 21702, USA.
Srinath SeshadriChemical Biology Laboratory, National Cancer Institute, Frederick, MD 21702, USA.
Ronald J HolewinskiProtein Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, MD 21702, USA.
Thorkell AndressonProtein Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, MD 21702, USA.
Adrian R Ferré-D'AmaréBiochemistry and Biophysics Center, National Heart, Lung and Blood Institute, Bethesda, MD 20892, USA.
Danny IncarnatoDepartment of Molecular Genetics, Groningen Biomolecular Sciences and Biotechnology Institute (GBB), University of Groningen, Groningen, the Netherlands.
John S SchneeklothChemical Biology Laboratory, National Cancer Institute, Frederick, MD 21702, USA. Electronic address: schneeklothjs@mail.nih.gov.
National Cancer Institute · USLeidos (United States) · USNational Heart Lung and Blood Institute · USFrederick National Laboratory for Cancer Research · USUniversity of Groningen · NL

Funding

Identification of Nucleic Acid Binding Small MoleculesZIABC011585 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SCHNEEKLOTH, JOHN · 2014 to 2025
$18.6M
RNA: New Antimicrobial StrategiesZIAHL006150 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI FERRÉ-D'AMARÉ, ADRIAN · 2012 to 2025
$11.8M
Intramural NIH HHS ZIA BC011585
6 · The paper itself

Abstract

Neuroblastoma RAS (NRAS) is an oncogene that is deregulated and highly mutated in cancers including melanomas and acute myeloid leukemias. The 5' untranslated region (UTR) (5' UTR) of the NRAS mRNA contains a G-quadruplex (G4) that regulates translation. Here we report a novel class of small molecule that binds to the G4 structure located in the 5' UTR of the NRAS mRNA. We used a small molecule microarray screen to identify molecules that selectively bind to the NRAS-G4 with submicromolar affinity. One compound inhibits the translation of NRAS in vitro but showed only moderate effects on the NRAS levels in cellulo. Rapid Amplification of cDNA Ends and RT-PCR analysis revealed that the predominant NRAS transcript does not possess the G4 structure. Thus, although NRAS transcripts lack a G4 in many cell lines the concept of targeting folded regions within 5' UTRs to control translation remains a highly attractive strategy.

Indexed as

G-QuadruplexesNeuroblastoma5' Untranslated RegionsCell LineGTP PhosphohydrolasesHumansMembrane ProteinsRNA, Messenger5' Untranslated RegionsGTP PhosphohydrolasesMembrane ProteinsNRAS protein, humanRNA, MessengerNRASRAS targetingRNA G-quadruplexRNA targetingsmall moleculesSMM screening strategy

Identifiers

PMID37257453
PMCPMC11623308
OpenAlexW4378952995

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.